Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Net Income

Aerie Pharmaceuticals Net Income Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Net Income from 2012 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Aerie Pharmaceuticals Net Income for the quarter ending September 09, 2020 was $-40m a -38.88% increase of 15m year over year
  • Aerie Pharmaceuticals Net Income for the last 12 months ending September 09, 2020 was $-192m a -3.93% increase of 8m year over year
  • Aerie Pharmaceuticals Annual Net Income for 2019 was $-200m a -16.53% increase of 33m from 2018
  • Aerie Pharmaceuticals Annual Net Income for 2018 was $-233m a 37.61% decrease of -87m from 2017
  • Aerie Pharmaceuticals Annual Net Income for 2017 was $-145m a 31.73% decrease of -46m from 2016
Other Income Statement Metrics:
  • Aerie Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $-51m a 21.13% decrease of -11m year over year
  • Aerie Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $7m
View Chart On Koyfin

Quarterly AERI Net Income Data

09/2020$-40m
06/2020$-48m
03/2020$-49m
12/2019$-55m
09/2019$-49m
06/2019$-47m
03/2019$-48m
12/2018$-51m
09/2018$-85m
06/2018$-55m

Annual AERI Net Income Data

2019$-200m
2018$-233m
2017$-145m
2016$-99m
2015$-74m
2014$-48m
2013$-31m
2012$-15m
2011$-13m